Table 2 Differences in baseline characteristics between patients with and without atrial fibrillation.
Variable | Atrial Fibrillation | No Fibrillation | p value |
|---|---|---|---|
Age, years | 61.57 ± 10.20 | 50.50 ± 11.94 | <0.01 |
Gender male, n (%) | 268 (83.23) | 68706 (78.64) | 0.04 |
High school or above, n (%) | 47 (14.60) | 18297 (20.94) | <0.01 |
Current smoker, n (%) | 88 (27.33) | 30401 (34.80) | <0.01 |
Current alcohol, n (%) | 107 (33.23) | 33268 (38.08) | 0.07 |
Active physical activity, n (%) | 75 (23.29) | 13605 (15.57) | <0.01 |
Snoring, n (%) | 63 (19.57) | 12392 (14.18) | <0.01 |
Hypertension, n (%) | 219 (68.01) | 37375 (42.78) | <0.01 |
Diabetes mellitus, n (%) | 39 (12.11) | 7738 (8.86) | 0.04 |
Dyslipidemia, n (%) | 120 (37.27) | 31081 (35.57) | 0.53 |
Myocardial infarction, n (%) | 13 (4.05) | 1038 (1.19) | <0.01 |
Body Mass Index, kg/m2 | 26.15 ± 3.89 | 25.06 ± 3.47 | <0.01 |
Systolic blood pressure, mmHg | 141.08 ± 21.24 | 130.20 ± 20.68 | <0.01 |
Diastolic blood pressure, mmHg | 86.36 ± 11.31 | 83.36 ± 11.69 | <0.01 |
Fasting blood glucose, mmol/L | 5.46 ± 1.65 | 5.46 ± 1.62 | 0.28 |
Total cholesterol, mmol/L | 4.89 ± 1.08 | 4.96 ± 1.15 | 0.22 |
Triglycerides, mmol/L | 1.72 ± 1.19 | 1.68 ± 1.38 | 0.05 |
Low-density lipoprotein, mmol/L | 2.18 ± 0.86 | 2.36 ± 0.88 | <0.01 |
High-density lipoprotein, mmol/L | 1.59 ± 0.44 | 1.54 ± 0.40 | 0.18 |
Uric acid, µmol/L | 313.82 ± 86.64 | 288.85 ± 83.02 | <0.01 |
High sensitivity C-reactive protein, mg/L | 1.18 (0.46–3.20) | 0.78 (0.30–2.00) | <0.01 |
